ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Gifts to NCI Totaled $332,226 In Fiscal 1986; Position Freeze Said To Hurt DCE Labs

January 3, 1986

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

September 7, 1990

NCI Cancer Center Support Grants Listed, 1989 vs. 1995

March 22, 1996

RFA On etiology Of AIDS, Kaposi’s

June 3, 1983

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002

New Mammography Guidelines Cut Uses By Women Under 50 t 25%

July 29, 1977